{"id":"W4241819020","doi":"10.1186/s12913-019-4829-z","title":"Correction to: Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis","year":2019,"lang":"en","type":"erratum","venue":"BMC Health Services Research","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; University of Saskatchewan","funders":"","keywords":"Biosimilar; Medicine; Mistake; Insulin glargine; Infliximab; Internet portal; Filgrastim; Insulin; Internal medicine; Intensive care medicine; Hypoglycemia; World Wide Web; The Internet; Law","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003713297,0.001505215,0.00133219,0.002744544,0.001990823,0.002618987,0.002501084,0.003944899,0.04860616],"category_scores_gemma":[0.07177578,0.0007106582,0.001238701,0.002921436,0.001496992,0.001184014,0.001063916,0.00663583,0.01708874],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007868948,"about_ca_system_score_gemma":0.01265355,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.196485,"about_ca_topic_score_gemma":0.1894207,"domain_scores_codex":[0.994848,0.0005717375,0.0008922229,0.0005763519,0.002603019,0.0005086584],"domain_scores_gemma":[0.9622651,0.00938391,0.001810303,0.001220214,0.02390007,0.001420404],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.00003101192,0.00000262059,0.0001573223,0.00008077627,0.000009841032,0.0001492855,0.00002311709,0.00003208542,0.00001751113,0.00028845,0.9955362,0.003671689],"study_design_scores_gemma":[0.00008791249,0.00002104235,0.002197025,0.0008060833,0.00008029732,0.001100076,0.0001379016,0.0003791001,0.0003493203,0.0009802023,0.9938005,0.00006065508],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"editorial","genre_gemma":"other","genre_scores_codex":[0.0006779897,0.001852958,0.001164391,0.1329966,0.8454325,0.00004815695,0.01190761,0.0004490213,0.005470784],"genre_scores_gemma":[0.06169785,0.01614568,0.0132855,0.2093912,0.312719,0.0003413805,0.02696103,0.004212388,0.355246],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.803515,"threshold_uncertainty_score":0.3906826,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04344575194558518,"score_gpt":0.3464683807633722,"score_spread":0.303022628817787,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}